Eupraxia Pharmaceuticals Statistics

Total Valuation

EPRX has a market cap or net worth of $439.33 million. The enterprise value is $386.93 million.

Market Cap	439.33M
Enterprise Value	386.93M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

EPRX has 61.50 million shares outstanding. The number of shares has increased by 17.76% in one year.

Current Share Class	61.50M
Shares Outstanding	61.50M
Shares Change (YoY)	+17.76%
Shares Change (QoQ)	+38.96%
Owned by Insiders (%)	18.14%
Owned by Institutions (%)	24.53%
Float	45.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.46
P/TBV Ratio	8.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.12, with a Debt / Equity ratio of 0.00.

Current Ratio	15.12
Quick Ratio	14.43
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -68.76% and return on invested capital (ROIC) is -42.70%.

Return on Equity (ROE)	-68.76%
Return on Assets (ROA)	-39.67%
Return on Invested Capital (ROIC)	-42.70%
Return on Capital Employed (ROCE)	-47.73%
Weighted Average Cost of Capital (WACC)	12.03%
Revenue Per Employee	n/a
Profits Per Employee	-$838,918
Employee Count	49
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, EPRX has paid $19,091 in taxes.

Income Tax	19,091
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +86.61% in the last 52 weeks. The beta is 1.42, so EPRX's price volatility has been higher than the market average.

Beta (5Y)	1.42
52-Week Price Change	+86.61%
50-Day Moving Average	7.47
200-Day Moving Average	6.62
Relative Strength Index (RSI)	47.38
Average Volume (20 Days)	162,362

Short Selling Information

The latest short interest is 2.57 million, so 4.18% of the outstanding shares have been sold short.

Short Interest	2.57M
Short Previous Month	2.54M
Short % of Shares Out	4.18%
Short % of Float	5.63%
Short Ratio (days to cover)	12.47

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.43M
Pretax Income	-38.59M
Net Income	-41.11M
EBITDA	-38.27M
EBIT	-38.43M
Earnings Per Share (EPS)	-$1.03

Full Income Statement

Balance Sheet

The company has $80.56 million in cash and $154,362 in debt, giving a net cash position of $80.41 million or $1.31 per share.

Cash & Cash Equivalents	80.56M
Total Debt	154,362
Net Cash	80.41M
Net Cash Per Share	$1.31
Equity (Book Value)	80.45M
Book Value Per Share	1.01
Working Capital	79.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$28.55 million and capital expenditures -$588,947, giving a free cash flow of -$29.14 million.

Operating Cash Flow	-28.55M
Capital Expenditures	-588,947
Depreciation & Amortization	164,404
Net Borrowing	n/a
Free Cash Flow	-29.14M
FCF Per Share	-$0.47

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

EPRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.76%
Shareholder Yield	-17.76%
Earnings Yield	-9.36%
FCF Yield	-6.63%

Analyst Forecast

The average price target for EPRX is $15.00, which is 110.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	110.97%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2